Study on the Treatment of Prurigo Nodularis With Stapokibart Injection

Summary

This study is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy and safety of Stapokibart Injection in the treatment of subjects with prurigo nodularis, and observe pharmacokinetic characteristics, pharmacological effects, and immunogenicity.

Timeline

Start

2024-06-25

Primary completion

2026-02-11

Completion

2026-02-11

Drugs

Indications